ZIOPHARM Oncology, Inc. (ZIOP) Stock Analysis
DELISTED
What happened to ZIOPHARM Oncology, Inc. (ZIOP) stock?
ZIOPHARM Oncology, Inc. (ZIOP) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $208M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
ZIOPHARM Oncology, Inc. (ZIOP). ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing immuno-oncology therapies for cancer patients. Their innovative platforms, like Sleeping Beauty and Controlled IL-12, aim to harness the body's immune system to fight tumors.
Last analyzed: May 10, 2026ZIOPHARM Oncology, Inc. (ZIOP) Healthcare & Pipeline Overview
More about this archive record
Can I still buy ZIOP shares?
No. ZIOP stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ZIOP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ZIOP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to ZIOPHARM Oncology, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.